Comparative evaluation of the Nanosphere Verigene RV+ assay and the Simplexa Flu A/B & RSV kit for detection of influenza and respiratory syncytial viruses
- PMID: 23152547
- PMCID: PMC3536264
- DOI: 10.1128/JCM.02504-12
Comparative evaluation of the Nanosphere Verigene RV+ assay and the Simplexa Flu A/B & RSV kit for detection of influenza and respiratory syncytial viruses
Abstract
Using retrospective (n = 200) and prospective (n = 150) nasopharyngeal specimens, we evaluated the Nanosphere Verigene RV+ and the Focus Diagnostics Simplexa Flu A/B & RSV tests. Overall, RV+ demonstrated sensitivities and specificities of 96.6% and 100% for influenza A virus, 100% and 99.7% for influenza B virus, and 100% and 100% for respiratory syncytial virus (RSV), while the Simplexa test sensitivities and specificities were 82.8 and 99.7%, 76.2 and 100%, and 94.6 and 100%, respectively.
References
-
- Ginocchio CC, Lotlikar M, Falk L, Arora S, Kowerska M, Bornfreund M, Manji R. 2009. Clinical performance of the 3M Rapid Detection Flu A+B test compared to R-Mix culture, DFA and BinaxNOW influenza A&B test. J. Clin. Virol. 45:146–149 - PubMed
-
- Miernyk K, Bulkow L, DeByle C, Chikoyak L, Hummel KB, Hennessy T, Singleton R. 2011. Performance of a rapid antigen test (Binax NOW(R) RSV) for diagnosis of respiratory syncytial virus compared with real-time polymerase chain reaction in a pediatric population. J. Clin. Virol. 50:240–243 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
